Evidence map›Paper›PMID 41468262›Full record

ArticleClinical nuclear medicine2026

18 F-FDG PET/CT in Rhabdomyosarcoma of the Prostate in an Infant.

Nina Schweighofer, Martina Filipič, Nataša Marčun Varda, Anka Cuderman, Veronika Kloboves Prevodnik, Emina Talakić

Abstract readCase Reports
In one paragraph

Article in Clinical nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nina SchweighoferDepartments of Radiology.
Martina FilipičPediatrics, University Medical Centre Maribor, Maribor.
Nataša Marčun VardaPediatrics, University Medical Centre Maribor, Maribor.
Anka CudermanClinic for Nuclear Medicine, University Medical Centre Ljubljana.
Veronika Kloboves PrevodnikDepartment of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Emina TalakićDepartment of Radiology, Division of General Radiology, Medical University of Graz, Graz, Austria.

Funding

no no
6 · The paper itself

Abstract

Rhabdomyosarcoma (RMS) of the prostate is a rare tumor in infants. RMS frequently arises in genitourinary tract (~20% of cases), with the embrional subtype being the most common. 1,2 The presenting symptoms are usually not specific, often leading to an extensive diagnostic work-up before identifying RMS. 3,4 Furthermore, there are no biomarkers specific to RMS. We present the case of a 4-month-old boy with postrenal acute kidney injury (AKI). Abdominal ultrasound and magnetic resonance imaging (MRI), followed by ultrasound-guided fine-needle aspiration biopsy and citopathological examination, established the diagnosis of prostatic RMS, which was later staged with 18 F-FDG PET/CT. 5.

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyProstatic NeoplasmsRhabdomyosarcomaHumansInfantMaleFluorodeoxyglucose F1818F-FDG PET/CTacute kidney injuryinfantpediatricprostaterhabdomyosarcoma

Identifiers

PMID41468262
PMCPMC12771971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.